Search details
1.
Exploring the Role of the Ω-Loop in the Evolution of Ceftazidime Resistance in the PenA ß-Lactamase from Burkholderia multivorans, an Important Cystic Fibrosis Pathogen.
Antimicrob Agents Chemother
; 61(2)2017 02.
Article
in English
| MEDLINE | ID: mdl-27872073
2.
Exposing a ß-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI ß-Lactamase.
Antimicrob Agents Chemother
; 60(2): 777-88, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26596949
3.
Insights into ß-lactamases from Burkholderia species, two phylogenetically related yet distinct resistance determinants.
J Biol Chem
; 288(26): 19090-102, 2013 Jun 28.
Article
in English
| MEDLINE | ID: mdl-23658015
4.
Reclaiming the efficacy of ß-lactam-ß-lactamase inhibitor combinations: avibactam restores the susceptibility of CMY-2-producing Escherichia coli to ceftazidime.
Antimicrob Agents Chemother
; 58(8): 4290-7, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24820081
5.
A kinetic analysis of the inhibition of FOX-4 ß-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic ß-lactams and carbapenems.
J Antimicrob Chemother
; 69(3): 682-90, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24235094
6.
Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type beta-lactamase genes in Gram-negative isolates.
J Clin Microbiol
; 48(7): 2618-22, 2010 Jul.
Article
in English
| MEDLINE | ID: mdl-20504993
7.
Sequence heterogeneity of the PenA carbapenemase in clinical isolates of Burkholderia multivorans.
Diagn Microbiol Infect Dis
; 92(3): 253-258, 2018 Nov.
Article
in English
| MEDLINE | ID: mdl-29983287
8.
Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients.
ACS Infect Dis
; 3(7): 502-511, 2017 07 14.
Article
in English
| MEDLINE | ID: mdl-28264560
9.
Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single ß-lactamases.
Diagn Microbiol Infect Dis
; 82(1): 65-9, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25737290
Results
1 -
9
de 9
1
Next >
>>